Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice.

J Am Geriatr Soc 2018 05 6;66(5):937-944. Epub 2018 Mar 6.

Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, Illinois.

Objectives: To describe medications that older hospice beneficiaries receive through Medicare Part D and assess patterns in Part D use for individuals admitted to hospice for cancer and noncancer causes.

Design: Descriptive cohort analysis using the Surveillance, Epidemiology and End Results (SEER)-Medicare linked database.

Setting: U.S. hospice programs PARTICIPANTS: Part D-enrolled Medicare beneficiaries aged 66 and older who were admitted to hospice and died while under hospice care between January 1, 2008, and December 31, 2013 (N = 88,957).

Measurements: We determined the 25 most commonly dispensed medications and the prevalence of at least 1 dispensing through Part D after hospice admission. The prevalence and temporal trends in receipt of opioid analgesics and several preventative medication classes are described.

Results: More than half of individuals admitted to hospice for cancer (53.5%) and noncancer causes (52.9%) received at least 1 medication through Part D after hospice admission. The prevalence of receiving at least 1 Part D medication after admission was greatest in individuals admitted for debility or failure to thrive (63.5%) and dementia (61.5%) and lowest in those admitted for ischemic stroke (35.4%) and renal disease (36.0%). Beta-blockers, angiotensin-converting enzyme inhibitors, proton pump inhibitors, and statins were among the most common preventative drug classes received overall, although prevalence differed according to admission diagnosis. Nearly 1 in 6 individuals received opioids through Part D after admission, with prevalence steadily decreasing over the study period.

Conclusion: Receipt of medications through Medicare Part D after hospice admission is common, particularly for preventative medications, and varies according to admission diagnosis. Further research aimed at better understanding individual-, provider-, and healthcare system-level contributors to nonpalliative medication use in the hospice population is warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgs.15328DOI Listing
May 2018
6 Reads

Publication Analysis

Top Keywords

admitted hospice
16
individuals admitted
12
admission prevalence
12
hospice admission
12
hospice
11
hospice cancer
8
common preventative
8
admission diagnosis
8
medication hospice
8
medicare beneficiaries
8
admission
7
admitted
6
medicare
5
prevalence
5
beneficiaries admitted
4
cancer 535%
4
535% noncancer
4
half individuals
4
describedresults half
4
classes describedresults
4

References

(Supplied by CrossRef)
Deaths: Final data for 2014
Kochanek et al.
Natl Vital Stat Rep 2016
Palliative care for the seriously ill
Kelley et al.
N Engl J Med 2015

2016

Tudor et al.
2013

Crosson et al.
2016

Chavez-Valdez et al.
2016

Similar Publications